0001567619-22-012194.txt : 20220602 0001567619-22-012194.hdr.sgml : 20220602 20220602182510 ACCESSION NUMBER: 0001567619-22-012194 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220531 FILED AS OF DATE: 20220602 DATE AS OF CHANGE: 20220602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burkavage Brian CENTRAL INDEX KEY: 0001865633 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41008 FILM NUMBER: 22992364 MAIL ADDRESS: STREET 1: C/O PASSAGE BIO, INC. STREET 2: ONE COMMERCE SQUARE, 39TH FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IO Biotech, Inc. CENTRAL INDEX KEY: 0001865494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870909276 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 BUSINESS PHONE: 4570702980 MAIL ADDRESS: STREET 1: OLE MAALOES VEH 3 CITY: COPENHAGEN STATE: G7 ZIP: 2200 4 1 doc1.xml FORM 4 X0306 4 2022-05-31 0 0001865494 IO Biotech, Inc. IOBT 0001865633 Burkavage Brian C/O IO BIOTECH, INC. OLE MAALOES VEH 3 COPENHAGEN G7 2200 DENMARK 0 1 0 0 Chief Accounting Officer Stock Option (Right to Buy) 4.83 2022-05-31 4 A 0 20000 0 A 2032-05-31 Common Stock 20000 20000 D One-fourth of these options vest on 5/31/2023, and 1/48th of these options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control. /s/ Brian Burkavage 2022-06-02